Gadofullerene inhibits the degradation of apolipoprotein B100 and boosts triglyceride transport for reversing hepatic steatosis

Hepatic steatosis is a widespread metabolic disease characterized by excessive accumulation of triglyceride (TG) in liver. So far, effective approved drugs for hepatic steatosis are still in development, and removing the unnecessary TG from the hepatocytes is an enormous challenge. Here, we explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chen, Zhen, Mingming, Yu, Meilan, Li, Xue, Yu, Tong, Liu, Jingchao, Jia, Wang, Liu, Shuai, Li, Lei, Li, Jie, Sun, Zihao, Zhao, Zhongpu, Wang, Xinyao, Zhang, Xiaoyan, Wang, Chunru, Bai, Chunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556997/
https://www.ncbi.nlm.nih.gov/pubmed/32917715
http://dx.doi.org/10.1126/sciadv.abc1586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556997/
https://www.ncbi.nlm.nih.gov/pubmed/32917715
http://dx.doi.org/10.1126/sciadv.abc1586

Ejemplares similares